Lunaphore has raised a $43M Series D to improve cancer research by making spatial biology mainstream.
The company claims its sales grew more than 350% over 2022.
Lunaphore aims to mainstream spatial biology by helping laboratories utilize technology and methods that revolve around this particular discipline.
- Spatial biology is a technology that maps the spatial architecture of a cell and the way it interacts with its surroundings.
- EGSB led the equity funding round, with participation from PHC Holdings Corporation, Swiss Entrepreneurs Fund, OCCIDENT, and Redalpine. Norgine Ventures led the debt portion of the round.
- The company is based in Lausanne, Switzerland.
- Since its inception in 2014, the company has raised nearly $100M.
